Screening to detect high blood pressure among coastal community dwellers and link them to appropriate care

Not Applicable

Conditions: Detection, and treatment of hypertension and prevention of hypertension-associated target organ damage
Circulatory System

Registration Number: ISRCTN76503336

Lead Sponsor: Deutsche Gesellschaft für Internationale Zusammenarbeit

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Ongoing

Sex: All

Target Recruitment: 10000

Inclusion Criteria

Current inclusion criteria as of 20/05/2024:

1. Resident in the Greater Accra Region of Ghana
2. Resident in the selected urban coastal communities
3. Aged 18 years or older as of last birthday
4. Have no intention of relocating outside of the study communities prior to enrolment and during the study period
5. Have a three-time blood pressure recording with a mean of =140/90mmhg at the time of recruitment
6. Newly diagnosed hypertensive; and
7. Willing to participate and has the ability to give consent.

_____

Previous inclusion criteria:

Adults 18 years and above in coastal communities in the Greater Accra Region of Ghana

Exclusion Criteria

1. Not a resident of the Greater Accra region and the selected coastal communities
2. Residents who intend to travel or re-locate before or during the study period
3. Known hypertensive participants who are already on medication
4. Known end-organ dysfunction on treatment
5. Not willing to participate in the study or do not give consent

Study & Design

Study Type: Observational

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Current primary outcome measure as of 20/05/2024: <br><br>Measured at baseline, 6, and 12 months:<br>1. Blood pressure measured using a sphygmomanometer<br>2. Hypertension mediated target organ damage (HMTOD):<br>2.1. ECG and ECHO for heart damage<br>2.2 Creatinine, proteinuria<br><br>_____<br><br>Previous primary outcome measure:<br><br>Measured at baseline, 6, and 12 months:<br>1. Blood pressure measured using a sphygmomanometer<br>2. Hypertension mediated target organ damage (HMTOD): <br>2.1. ECG and ECHO for heart damage<br>2.2. Proteinuria and Creatinine for kidney damage

Secondary Outcome Measures